Sex and gender-tailored screening strategies aim to address disparities in colorectal cancer detection and participation
Experts identify ways to improve colorectal cancer screening for everyone
This consensus study identifies significant disparities in colorectal cancer incidence, age of onset, and screening participation between me…
Men and women face different barriers and risks when it comes to colorectal cancer, making tailored screening strategies vital for better he…
Encorafenib and Binimetinib Combination Therapy for Patients with BRAF Mutated Cutaneous Melanoma
Trial Shows Encorafenib and Binimetinib for Melanoma Patients
This trial evaluates the safety and efficacy of encorafenib and binimetinib in patients with resected stage IIB/IIC melanoma.
A clinical trial shows that a combination of encorafenib and binimetinib may improve recurrence-free survival for patients with specific mel…
Gut microbiome composition correlates with clinical outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
Gut bacteria may influence how liver cancer patients respond to treatment
This meta-analysis of 13 papers examines the relationship between gut microbiota and clinical outcomes in patients with intermediate-to-adva…
Specific types of gut bacteria are linked to how well liver cancer patients respond to immune-based therapies.
Alemtuzumab-based therapy achieves 81.9% response rate in adult T-cell prolymphocytic leukemia
Alemtuzumab Therapy Shows High Response Rates for T-cell Leukemia
This meta-analysis of 200 patients with T-cell prolymphocytic leukemia (T-PLL) found an 81.9% overall response rate to alemtuzumab-based the…
Alemtuzumab-based therapy shows an 81.9% response rate for adults with T-cell prolymphocytic leukemia, with some patients surviving long-ter…
Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation
Thoracic radiation for cancer may increase risk of heart rhythm issues
This meta-analysis of 9 cohort-level estimates examines reported atrial fibrillation after thoracic radiotherapy in adults with thoracic mal…
New data shows that patients receiving radiation for chest cancers may face a higher risk of developing atrial fibrillation, a common heart …
HER2-low breast cancer shows distinct survival trajectories versus HER2-positive in systematic review
HER2-Low Status Shows Distinct Survival Paths in Breast Cancer
This systematic review of 10 trials synthesizes evidence on survival outcomes in HER2-low versus HER2-positive breast cancer. The authors re…
New analysis shows that HER2-low breast cancer tumors follow different survival paths than HER2-positive tumors, which may help doctors plan…
Minimally invasive nipple-sparing mastectomy reduces surgical trauma and postoperative complications in breast cancer patients
Minimally invasive surgery may reduce complications after breast cancer surgery
This meta-analysis evaluates minimally invasive nipple-sparing mastectomy (NSM) compared to conventional open NSM for breast cancer patients…
Minimally invasive techniques for breast cancer surgery may lead to less blood loss and fewer complications like skin death or fluid buildup…
FDA Approves Hyrnuo (zongertinib) for HER2 TKD Mutant Non-Squamous NSCLC After Prior Therapy
FDA Approves New Targeted Drug for a Type of Lung Cancer
The FDA granted accelerated approval to Hyrnuo (zongertinib) for adults with locally advanced or metastatic non-squamous NSCLC harboring HER…
The FDA has approved Hyrnuo for adults with advanced non-small cell lung cancer that has a specific HER2 gene change. It is for patients who…
Evaluating AI and Manual Stromal Immune Cell Quantification in HER2 Positive Breast Cancer
AI tools help predict outcomes for HER2-positive breast cancer
This Phase 3 analysis evaluates how manual, digital, and AI-based sTIL quantification impact prognostic and predictive outcomes in HER2+ bre…
New analysis shows that AI and manual counts of immune cells can help predict how well patients with HER2-positive breast cancer respond to …
Dose Escalated Radiotherapy Combined With Androgen Deprivation Improves Outcomes in High Risk Prostate Cancer
Higher radiation doses may improve long-term outcomes for prostate cancer
A Phase 3 trial demonstrates that 80 Gy of radiotherapy plus long-term ADT significantly improves 10-year progression-free survival.
A large trial shows that a higher dose of radiation combined with hormone therapy may help men with high-risk prostate cancer stay cancer-fr…
Triple Combination Therapy Improves Progression-Free Survival in Patients with Hepatocellular Carcinoma
Trial shows STRIDE plus lenvatinib improves progression-free survival for HCC
A Phase 3 trial demonstrates that combining tremelimumab, durvalumab, and lenvatinib with TACE significantly extends progression-free surviv…
A new combination of drugs and TACE treatment may extend the time before liver cancer progresses for patients with hepatocellular carcinoma.
Ivonescimab Combined With Chemotherapy Improves Progression Free Survival in EGFR Mutated NSCLC
Trial shows ivonescimab plus chemotherapy improves lung cancer outcomes
Ivonescimab plus pemetrexed and carboplatin significantly extends progression-free survival for patients with advanced EGFR-mutated NSCLC.
A new treatment combination involving ivonescimab and chemotherapy showed a significant improvement in progression-free survival for certain…